Frontiers in Oncology | Breast Cancer

Systematic Review

Published on 01 May 2024

A bibliometric analysis of HER2-positive breast cancer: 1987–2024

in Breast Cancer

Sherlissa Ali-Thompson
Gordon R. Daly
Gavin P. Dowling
Conor Kilkenny
Luke Cox
Jason McGrath
Ma’en M. AlRawashdeh
Sindhuja Naidoo
Colm Power
Arnold D. K. Hill

Frontiers in Oncology

doi 10.3389/fonc.2024.1355353

2,844 views
4 citations

Original Research

Published on 01 May 2024

Residual OXPHOS is required to drive primary and metastatic lung tumours in an orthotopic breast cancer model

in Breast Cancer

Patries Herst
Georgia Carson
Danielle Lewthwaite
David Eccles
Alfonso Schmidt
Andrew Wilson
Carole Grasso
David O’Sullivan
Jiri Neuzil
Melanie McConnell

Frontiers in Oncology

doi 10.3389/fonc.2024.1362786

1,784 views

Case Report

Published on 30 Apr 2024

The treatment process of a giant phyllodes tumor of the breast: a case report and review of the literature

in Breast Cancer

Yujun Tong
Siyu Liu
Lijuan Zhao
Zhen Zhang
Haiyan Hu
Yu Jing
Tiantian Liang

Frontiers in Oncology

doi 10.3389/fonc.2024.1382985

1,290 views

Systematic Review

Published on 26 Apr 2024

Conservative medical intervention as a complement to CDT for BCRL therapy: a systematic review and meta-analysis of randomized controlled trials

in Breast Cancer

Chuyu Deng
Zhiguo Wu
Zijie Cai
Xiaoyan Zheng
Chunzhi Tang

Frontiers in Oncology

doi 10.3389/fonc.2024.1361128

3,049 views

Case Report

Published on 26 Apr 2024

Case report: From negative to positive: a remarkable journey of ER, PR and HER2 status in a patient with metastatic breast cancer

in Breast Cancer

Jiaqi Huang
Lan Liu
Jianghua Ding

Frontiers in Oncology

doi 10.3389/fonc.2024.1381541

1,207 views

Review

Published on 25 Apr 2024

BRCA testing and management of BRCA-mutated early-stage breast cancer: a comprehensive statement by expert group from GCC region

in Breast Cancer

Humaid O. Al-Shamsi
Ahmed Alwbari
Fathi Azribi
Francois Calaud
Sanjay Thuruthel
Syed Hammad Hassan Tirmazy
Sharif Kullab
Sonia Ostomane
Omalkhair Abulkhair

Frontiers in Oncology

doi 10.3389/fonc.2024.1358982

5,536 views

Original Research

Published on 24 Apr 2024

The expression and role of the Lem-D proteins Ankle2, Emerin, Lemd2, and TMPO in triple-negative breast cancer cell growth

in Breast Cancer

Maddison Rose
Joshua T. Burgess
Chee Man Cheong
Mark N. Adams
Parastoo Shahrouzi
Kenneth J. O’Byrne
Derek J. Richard
Emma Bolderson

Frontiers in Oncology

doi 10.3389/fonc.2024.1222698

1,478 views

Original Research

Published on 23 Apr 2024

The functional role of Nudt2 in human triple negative breast cancer

in Breast Cancer

Rasha Abu-Rahmah
Hovav Nechushtan
Sanaa Hidmi
Amichay Meirovitz
Ehud Razin
Tamar Peretz

Frontiers in Oncology

doi 10.3389/fonc.2024.1364663

1,068 views
2 citations

Case Report

Published on 19 Apr 2024

Malignant phyllodes tumor of the breast with predominant osteosarcoma and chondrosarcomatous differentiation: a rare case report and review of literature

in Breast Cancer

Wenfang Li
Qin Ou
Yingdong Li
Linlin Yuan Yuan

Frontiers in Oncology

doi 10.3389/fonc.2024.1372710

1,889 views
2 citations

Review

Published on 18 Apr 2024

Potential therapeutic targets of the JAK2/STAT3 signaling pathway in triple-negative breast cancer

in Breast Cancer

Lin Long
Xiangyu Fei
Liucui Chen
Liang Yao
Xiaoyong Lei

Frontiers in Oncology

doi 10.3389/fonc.2024.1381251

3,927 views
6 citations

Case Report

Published on 18 Apr 2024

GLP-1 receptor agonist as an effective treatment for breast cancer-related lymphedema: a case report

in Breast Cancer

Fionnuala Crowley
Stav Brown
Emily J. Gallagher
Joseph H. Dayan

Frontiers in Oncology

doi 10.3389/fonc.2024.1392375

7,871 views
1 citation

Clinical Trial

Published on 18 Apr 2024

App-based support for breast cancer patients to reduce psychological distress during therapy and survivorship – a multicentric randomized controlled trial

in Breast Cancer

Josefine Wolff
Svenja Seidel
Pia Wuelfing
Michael Patrick Lux
Christine zu Eulenburg
Martin Smollich
Freerk Baumann
Stephan Seitz
Sherko Kuemmel
Marc Thill

Frontiers in Oncology

doi 10.3389/fonc.2024.1354377

4,953 views
5 citations

Review

Published on 18 Apr 2024

A contemporary review of breast cancer risk factors and the role of artificial intelligence

in Breast Cancer

Orietta Nicolis
Denisse De Los Angeles
Carla Taramasco

Frontiers in Oncology

doi 10.3389/fonc.2024.1356014

5,332 views
7 citations

Original Research

Published on 16 Apr 2024

Trends in breast cancer mortality attributable to metabolic risks in Chinese women from 1990 to 2019: an age-period-cohort analysis

in Breast Cancer

Ting Zhang
Simeng Sun
Ting Xia
Qiaoyu Huang
Yali Fu
Weiwei Wang
Huafeng Yang
Xin Hong
Nan Zhou
Hao Yu

Frontiers in Oncology

doi 10.3389/fonc.2024.1369027

1,433 views

Case Report

Published on 16 Apr 2024

Case report: An ultrasound-based approach as an easy tool to evaluate hormone receptor-positive HER-2-negative breast cancer in advanced/metastatic settings: preliminary data of the Plus-ENDO study

in Breast Cancer

Liliana Montella
Luigi Di Marino
Maria Adele Marino
Vittorio Riccio
Nunzio Del Gaudio
Lucia Altucci
Massimiliano Berretta
Gaetano Facchini

Frontiers in Oncology

doi 10.3389/fonc.2024.1295772

1,160 views

Original Research

Published on 15 Apr 2024

scRNA-seq characterizing the heterogeneity of fibroblasts in breast cancer reveals a novel subtype SFRP4+ CAF that inhibits migration and predicts prognosis

in Breast Cancer

Lvwen Ning
Chuntao Quan
Yue Wang
Zhijie Wu
Peixiu Yuan
Ni Xie

Frontiers in Oncology

doi 10.3389/fonc.2024.1348299

3,340 views
1 citation

Navigation group

Articles

A bibliometric analysis of HER2-positive breast cancer: 1987–2024

Residual OXPHOS is required to drive primary and metastatic lung tumours in an orthotopic breast cancer model

The treatment process of a giant phyllodes tumor of the breast: a case report and review of the literature

Conservative medical intervention as a complement to CDT for BCRL therapy: a systematic review and meta-analysis of randomized controlled trials

Case report: From negative to positive: a remarkable journey of ER, PR and HER2 status in a patient with metastatic breast cancer

BRCA testing and management of BRCA-mutated early-stage breast cancer: a comprehensive statement by expert group from GCC region

The expression and role of the Lem-D proteins Ankle2, Emerin, Lemd2, and TMPO in triple-negative breast cancer cell growth

The functional role of Nudt2 in human triple negative breast cancer

Malignant phyllodes tumor of the breast with predominant osteosarcoma and chondrosarcomatous differentiation: a rare case report and review of literature

Potential therapeutic targets of the JAK2/STAT3 signaling pathway in triple-negative breast cancer

GLP-1 receptor agonist as an effective treatment for breast cancer-related lymphedema: a case report

App-based support for breast cancer patients to reduce psychological distress during therapy and survivorship – a multicentric randomized controlled trial

A contemporary review of breast cancer risk factors and the role of artificial intelligence

Trends in breast cancer mortality attributable to metabolic risks in Chinese women from 1990 to 2019: an age-period-cohort analysis

Case report: An ultrasound-based approach as an easy tool to evaluate hormone receptor-positive HER-2-negative breast cancer in advanced/metastatic settings: preliminary data of the Plus-ENDO study

scRNA-seq characterizing the heterogeneity of fibroblasts in breast cancer reveals a novel subtype SFRP4+ CAF that inhibits migration and predicts prognosis